Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is... see more

Bullboard (CSE:RVV)

View:
Post by cool888on Feb 12, 2023 11:29am

The Fast-Spreading New COVID-19 Subvariant XBB

#Bucillamine https://www.msn.com/en-ca/health/medical/the-fast-spreading-new-covid-19-subvariant-xbb-is-part-of-a-new-class-of-omicron/ar-AA133Y9C?ocid=msedgntp&cvid ...more  
Post by CrazyPropheton Feb 10, 2023 8:18am

We have a lot of things going on exciting

things that will move this share price IMO bigtime https://time.com/6253702/psychedelics-psilocybin-mdma-legalization/ It came as a surprise to many when, on Feb. 3, Australian regulators  ...more  
Post by cool888on Feb 09, 2023 6:33pm

Bivalent COVID Vaccines Perform Worse Against Variant !

#Bucillamine https://www.theepochtimes.com/health/bivalent-covid-vaccines-perform-worse-against-variant-now-dominant-in-united-states-studies_5040659.html?utm_source=partner&utm_campaign ...more  
Post by CrazyPropheton Feb 09, 2023 12:23pm

Just about ready to

go on boil ? It has to be very very close lots of support seems to have stopped buying after loading up and perched waiting for the go signs ???
Comment by cool888on Feb 09, 2023 10:42am

RE:Interesting Article !

Full article  https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.investorvillage.com/groups.asp%3Fmb%3D19572%26mn%3D7038%26pt%3Dmsg%26mid%3D23894157&ved ...more  
Post by cool888on Feb 09, 2023 9:53am

Interesting Article !

#Bucillamine  https://t.co/CuQWIfJFqi
Comment by 90guppyon Feb 07, 2023 10:56am

RE:RE:$PHRM - fyi ..

COOL DA-FOOL, what do you mean no control in type c, DUH!, they are the one providing answers to the fda questions, if rvv provide sh1ts!, they will get sh1t reply from fda, so rvv for the last ...more  
Comment by 90guppyon Feb 07, 2023 9:19am

RE:$PHRM - fyi ..

COOL DA- FOOL. You can pump sh1ts this thing, but this wont matter to rvv, all that matters is the type c, COOL DA-FOOL, that what you have to tell to mfrank, mess up the type c and this thing go ...more  
Post by cool888on Feb 07, 2023 9:07am

$PHRM - fyi ..

https://ca.finance.yahoo.com/news/pharmather-submits-fda-meeting-package-125900274.html
Comment by 90guppyon Feb 06, 2023 1:05pm

RE:$RVV - fyi !

COOL DA-FOOL, email rvv mgt and bug them not to mess up the type c, you can post anysh1t you want but it wont be any help unless rvv passed that type c. COOL- DA FOOL!
Post by cool888on Feb 06, 2023 12:38pm

$RVV - fyi !

https://twitter.com/i/spaces/1mrGmkAMVEzxy
Post by CrazyPropheton Feb 06, 2023 8:33am

Sounds like a solid move !!!

https://financialpost.com/globe-newswire/revive-therapeutics-secures-mdma-supply-from-pharmala-biotech-for-mdma-transdermal-patch-development
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities